Patient: Page 6


  • Elle de Groot Brii Bioscience
    Image attribution tooltip
    Permission granted by Elle de Groot
    Image attribution tooltip
    Podcast

    Woman of the Week: Brii Biosciences’ Ellee de Groot

    A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.

    By April 19, 2023
  • Young people sitting on the stairs and using smartphones.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Patient influencers are here to stay — where are the regulations?

    As social media health influencers enter the world of pharma advertising, experts warn that more guardrails are needed to protect the industry and patients.

    By Karissa Waddick • April 17, 2023
  • digital pill Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Artificial intelligence & machine learning

    After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

    By PharmaVoice staff
  • Julia Lakeland uMotif
    Image attribution tooltip
    Permission granted by Julia Lakeland uMotif
    Image attribution tooltip
    Podcast

    Woman of the Week: uMotif’s Julia Lakeland

    The chief product officer’s work in transforming clinical trial technology is driven by people.

    By April 12, 2023
  • A councelor comforting her emotional patient and taking notes during therapy session.
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What’s pharma doing wrong to improve trial diversity? ‘Everything’

    Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.

    By Karissa Waddick • April 12, 2023
  • blood sample tubes
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Where one unicorn struggled, another biotech is aiming for a diabetes win

    Intarcia looked poised to break into a lucrative diabetes implant market but has been dogged by safety issues — now Vivani thinks it’s found a way to succeed.

    By Kelly Bilodeau • April 10, 2023
  • Shot of a young woman using a cellphone while relaxing at home
    Image attribution tooltip
    Adene Sanchez via Getty Images
    Image attribution tooltip
    Sponsored by GoodRx

    GoodRx Health is the one-stop-shop for patients — and marketers

    Optimize patient conversion through a single platform with GoodRx: the one-stop-shop for patients — and marketers.

    April 10, 2023
  • Peyton Howell Parexel
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Q&A

    5 minutes with — Parexel’s Peyton Howell

    The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."

    By April 7, 2023
  • A scientist with protective eyeglasses and mask holding a red transparent pill with fingers in gloves in the pharmaceutical research laboratory
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A drug just launched for a disease discovered only 10 years ago

    Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.

    By Karissa Waddick • April 6, 2023
  • cardio
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Q&A

    Amgen’s aim for a ‘moonshot’ in cardiovascular disease

    A VP of global development at Amgen explains how treating general medicine diseases could one day resemble approaches in oncology.  

    By April 5, 2023
  • dollar bill brain
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    All eyes turn to Karuna as it aims for an approval of a would-be blockbuster

    In the red-hot race for new schizophrenia treatments, Karuna Therapeutics is close to an FDA submission.

    By Kelly Bilodeau • April 3, 2023
  • magic wand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Leaders wave a magic wand at pharma’s thorniest issues

    The major challenges pharma leaders would solve with a quick flick of an imaginary wand.

    By PharmaVoice staff • March 31, 2023
  • A whiteboard with a stick-figure smiling phage sits on a desk in biotech laboratory
    Image attribution tooltip
    Karissa Waddick/PharmaVoice
    Image attribution tooltip

    Predator and prey: Harnessing phages to fight antibiotic resistance

    Phages, bacteria’s natural predator, could help combat the growing threat of superbugs. But can these therapies rise above antibiotic market woes?

    By Karissa Waddick • March 30, 2023
  • pill explosion
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Seamless clinical trials were created to make studies easier — instead, they’ve become more complex

    Experts weigh in on how companies can design better trials that merge two phases into one.

    By March 29, 2023
  • magic wand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    What would you fix with a ‘magic wand?’ Pharma leaders chime in about clinical trials

    How life science execs would transform clinical trials with a little hocus pocus.

    By PharmaVoice staff • March 24, 2023
  • High angle shot of people reaching to connect puzzle pieces together
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Everyone says they’re patient-centric, but have they really walked the walk?

    Life science leaders provide practical tips on how to create a sustainable patient-focused culture.

    By Karissa Waddick • March 23, 2023
  • wuhan
    Image attribution tooltip
    Getty via Getty Images
    Image attribution tooltip

    Viral roots: A look at how modern outbreaks began

    As experts wrestle with COVID-19’s lab leak versus animal market debate, here’s what experts say are the suspected origins for some of the worst viral outbreaks in the last century.

    By March 22, 2023
  • Magical, illuminated mushroom growing on a moss
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    ‘The Last of Us’ might be fiction, but fungi are a looming threat

    Fungal infections are a growing challenge for hospitalized patients, and new treatments are badly needed.

    By Kelly Bilodeau • March 20, 2023
  • Nobel Peace Prize
    Image attribution tooltip
    Chris Jackson/Getty Images via Getty Images
    Image attribution tooltip

    A biopharma CEO’s quest for global health equity has put him in the running for a Nobel Prize

    Dr. Ryan Saadi, CEO of Tevogen Bio, is making good on a lifelong goal of bringing T cell therapies to people who need them.

    By March 17, 2023
  • A glass building with a sign that reads,  "Biogen."
    Image attribution tooltip

    Paul Marotta/Sipa USA/Newscom

    Image attribution tooltip
    Making Moves

    In the fallout from Aduhelm, Biogen’s leadership shakeup continues

    The recent departure of neurodegenerative development head Samantha Budd Haeberlein is just the latest sign of a changing tide among Biogen’s post-Aduhelm leadership.

    By Karissa Waddick • March 16, 2023
  • hands connecting healthcare
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Profile

    The power of connections for a startup CEO

    Priyanka Dutta-Passecker, head of wound-care specialist Healiva, discusses the importance of tapping her network in starting and running a biotech.

    By Alexandra Pecci • March 14, 2023
  • Babson Diagnostics
    Image attribution tooltip
    Permission granted by Babson Diagnostics
    Image attribution tooltip
    Q&A

    Babson aims to shed Theranos curse with new blood testing tech

    Babson Diagnostics is trying to create a less invasive blood testing technology — can it gain trust in the post-Theranos era?

    By Kelly Bilodeau • March 13, 2023
  • Pharmacist talking with customer about medicine bottle in drugstore.
    Image attribution tooltip
    simonkr via Getty Images
    Image attribution tooltip
    Sponsored by GoodRx

    Across therapy areas, GoodRx’s POS rebates improve access and affordability for cash-paying patients

    Across therapy areas, GoodRx Assist is a proven point-of-sale rebate program for cash-paying patients.

    March 13, 2023
  • Murray Aitken IQVIA Institute
    Image attribution tooltip
    Permission granted by Murray Aitken/IQVIA Institute
    Image attribution tooltip
    Q&A

    IQVIA’s OG of data analytics on the latest clinical trial trends

    IQVIA Institute’s Murray Aitken is the man behind the numbers, and here, shares the newest findings on clinical trial burnout, diversity and more.

    By March 10, 2023
  • Senior older women
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Targeting the new ‘Golden Girls’

    With unprecedented buying power, women over 50 wield a lot of influence — but are still underserved by pharma. Urovant hopes to change that with its potential blockbuster drug.

    By March 8, 2023
  • storytelling marketing
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    3 keys to good storytelling in pharma

    The CEO of Complement Therapeutics shares simple storytelling tactics lead to maximum impact.

    By Alexandra Pecci • March 7, 2023